- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats
© Chen et al.; licensee BioMed Central Ltd. 2012
- Received: 19 April 2012
- Accepted: 17 October 2012
- Published: 23 November 2012
Lonicera japonica Thunb. (Caprifoliaceae), a widely used traditional Chinese medicinal plant, is used to treat some infectious diseases and it may have uses as a healthy food and applications in cosmetics and as an ornamental groundcover. The ethanol extract of the flowering aerial parts of L. japonica (LJEE) was investigated for its healing efficiency in a rat excision wound model.
Excision wounds were inflicted upon three groups of eight rats each. Healing was assessed by the rate of wound contraction in skin wound sites in rats treated with simple ointment base, 10% (w/w) LJEE ointment, or the reference standard drug, 0.2% (w/w) nitrofurazone ointment. The effects of LJEE on the contents of hydroxyproline and hexosamine during healing were estimated. The antimicrobial activity of LJEE against microorganisms was also assessed. The in vivo anti-inflammatory activity of LJEE was investigated to understand the mechanism of wound healing.
LJEE exhibited significant antimicrobial activity against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Candida albicans, and Candida tropicalis. The ointment formulation prepared with 10% (w/w) LJEE exhibited potent wound healing capacity as evidenced by the wound contraction in the excision wound model. The contents of hydroxyproline and hexosamine also correlated with the observed healing pattern. These findings were supported by the histopathological characteristics of healed wound sections, as greater tissue regeneration, more fibroblasts, and angiogenesis were observed in the 10% (w/w) LJEE ointment-treated group. The results also indicated that LJEE possesses potent anti-inflammatory activity, as it enhanced the production of anti-inflammatory cytokines that suppress proinflammatory cytokine production.
The results suggest that the antimicrobial and anti-inflammatory activities of LJEE act synergistically to accelerate wound repair.
The function of skin is to serve as a protective barrier against the environment. Wounds are physical injuries that result in an opening or break of the skin. Wound healing involves continuous cell-cell and cell-matrix interactions that allow the process to proceed in three overlapping phases: inflammation (0–3 days), cellular proliferation (3–12 days), and remodeling (3–6 months) . During the inflammatory stage, neutrophils and macrophages infiltrate the wound site and phagocytose infectious agents, and the degraded tissue fragments release proteases and various reactive oxygen species (ROS) into the wound environment . They also are both major sources and targets of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFα) and interleukin (IL)-1, which have been revealed as key mediators that promote necrosis factor-κB activation and ROS production during cutaneous inflammatory processes . ROS play crucial roles in cell signaling and immune responses, but they also cause oxidative stress at higher levels during wound healing. Wound healing has been associated with a decrease in pro-inflammatory cytokine levels .
Lonicera japonica Thunb. (Caprifoliaceae), a widely used traditional Chinese medicinal plant that is also calledJin Yin Hua, Ren Dong, and Japanese honeysuckle, is native to eastern Asia, including Japan, Korea, northern and eastern China, and Taiwan, but it is a major invasive species in North America. L. japonica is traditionally used as a medicinal plant . However, it is also used as a food, cosmetic and ornamental groundcover, and it can be consumed as a healthy beverage . The ethnopharmacological studies and clinical findings have demonstrated that L. japonica possesses many biological functions, including hepatoprotective, cytoprotective, antimicrobial, antioxidative, antiviral, and anti-inflammatory properties . The major parts of this plant have medicinal properties: the flower buds have anticancer and anti-inflammatory properties , the leaves have antioxidant and tyrosinase-inhibitory properties , and the stem has tyrosinase-inhibitory, xanthine oxidase-inhibitory, and nitrite-scavenging activities .
The potent anti-inflammatory and ethnopharmacological properties of L. japonica make it an excellent source of novel medicinal targets for wound healing, as there are currently no studies of the effects of such herbs on healing chronic wounds. Therefore, the present study assessed the effects of the ethnobotanical use of L. japonica on various parameters and stages of the wound healing process, and its antimicrobial activity was evaluated to clarify the mechanism by which L. japonica promotes wound healing.
Plant material and extraction
The flowering aerial parts of L. japonica were collected from Ligang Township (Pingtung County, Taiwan) in October 2010. Macroscopic and microscopic examinations, thin-layer chromatography, and high-performance liquid chromatography (HPLC) were used to confirm the authenticity of the plant material provided (this analysis was performed by Dr. Hong T.Y., Department of Biotechnology, Collage of Pharmacy and Health Care, Tajen University). The voucher specimen (Lot No. LJ 20101021) has been preserved in our laboratory for future reference.
The flowering aerial parts of L. japonica were air-dried, pulverized to a coarse powder in a mechanical grinder, and passed through a 40-mesh sieve to get powdered samples. Powdered samples (5 kg) were extracted at room temperature thrice with 10 L of 95% ethanol for 48 h on an orbital shaker to make the ethanol extracts. The L. japonica ethanol extract (LJEE) was evaporated to dryness under reduced pressure to completely eliminate alcohol and lyophilized, yielding approximately 563 g of dry residue (w/w yield: 11.3%). LJEE was stored at −20°C until use and suspended in distilled water. The chlorogenic acid content of the samples was then analyzed using an HPLC protocol, and the antimicrobial activity was screened as described in subsequent sections.
Chlorogenic acid content analysis
The chlorogenic acid content in was quantified using an Agilent 1200 Series HPLC system with a Thermo Scientific BDS Hypersil Phenyl Column (4.6 mm × 100 mm). The mobile phase of the optimized chromatographic method consisted of solvent A (methanol) and solvent B (0.5% (v/v) acetic acid in water). The elution profile was as follows: 0 min 10% A in B, 28.6 min 60% A in B, 30 min 10% A in B. The mobile phase was passed under vacuum through a 0.45-μm membrane filter before use. The flow rate was 1 ml/min, and injection volume was 10 mL. Absorption was measured at 280 nm. The identity of chlorogenic acid was determined by matching the UV spectrum and retention time with those of the standard. Chlorogenic acid (purity ≥ 95.0%, Sigma-Aldrich, Inc., St. Louis, MO, USA; Cat. No. C3878) was used at the concentrations of 12.5 to 400 μg/ml to construct the calibration curve. The retention time of this compound was 12.4 min. The amount of chlorogenic acid present was quantified using the peak areas. Chlorogenic acid content was expressed as μg/g of the dry extract. All samples were performed in triplicate.
The agar diffusion method was used to evaluate the antimicrobial activity . The microorganisms used for the antimicrobial activity were Staphylococcus aureus (ATCC 29213), Staphylococcus epidermidis (ATCC 155), Escherichia coli (ATCC 23815), Candida albicans (ATCC 90028), and Candida tropicalis (ATCC 20401). These organisms were identified and procured from the Bioresource Collection and Research Center of the Food Industry Research and Development Institute (Hsinchu, Taiwan).
Bacteria were cultured overnight at 37°C in Mueller Hinton Broth (Oxoid), and fungi were cultured at 28°C for 72 h in Potato Dextrose Broth (Oxoid). The final inoculum size was 100 μl, and the inocula consisting of suspensions containing 1×108 CFU/ml bacteria or 1×104 spore/ml fungi were spread onto Mueller Hinton Agar and Potato Dextrose Agar medium, respectively. Each disc (6 mm in diameter) was impregnated with 10 μl of 100 mg/ml (1 mg/disc) LJEE. Gentamicin (10 μg/disc) and tetracycline (10 μg/disc) were used as positive controls for bacteria, and fluconazole (10 μg/disc) and ketoconazole (10 μg/disc) were used as positive controls for fungi. Gentamicin (Cat. No. G1914), tetracycline (Cat. No. T3258), fluconazole (Cat. No. F8929), and ketoconazole (Cat. No. K1003) were obtained from Sigma-Aldrich, Inc. The test plates were incubated at 37°C for 24 h for bacteria and at 28°C for 72 h for fungi depending on the incubation time required for visible growth. The minimum inhibitory concentration (MIC) values were also studied for microorganisms that exhibited sensitivity to LJEE in the disc diffusion assay. Sterile filter paper discs (6 mm in diameter) containing 2.5-1000 μg/disc of all the components were placed on the surface of the medium. The MIC was defined as the lowest concentration of extract that inhibited visible growth on agar.
Male Wistar rats (200–250 g, 6–8 weeks old) were obtained from the National Laboratory Animal Center (Taipei, Taiwan). They were maintained in a temperature-controlled room (25 ± 1°C) and kept on a 12:12 light–dark cycle in our animal center. Food and water were available ad libitum. The rats were used after acclimatization to the laboratory environment for a 7-day period. All animal procedures were performed according to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health as well as the guidelines of the Animal Welfare Act. These studies were conducted with the approval of the Institutional Animal Care and Use Committee (IACUC) at Tajen University (approval number: IACUC 99–24; approval date: December 23, 2010).
Excision wound model
Three groups with eight animals in each group were anaesthetized by the open mask method with anesthetic ether. The backs of the rats were depilated. One excision wound was inflicted by cutting away a 500-mm2 section of the full thickness of the skin from a predetermined area. The wound was left undressed to the open environment. Group 1 rats were dressed with simple ointment composed of 5% (w/w) wool fat, 5% (w/w) hard paraffin, 5% (w/w) cetostearyl alcohol, and 85% (w/w) white soft paraffin. Wounds of experimental animals (Group 2 and 3) were treated with the 10% (w/w) LJEE ointment and Nitrofurazone ointment (0.2%, w/w), respectively. The 10% (w/w) LJEE ointment was composed of 10 g of LJEE incorporated into 100 g of a simple ointment base. Nitrofurazone ointment (0.2%, w/w) (GSK Pharmaceuticals, Bangalore, India) was used as a reference standard drug to assess the wound-healing potential of the LJEE ointment. Simple ointment, LJEE ointment (10%, w/w) and the reference standard drug were applied topically (dose, approximately 0.20 g/wound) once daily. Special care was taken to avoid variation in the dose given. The wound area was traced on a sheet of sterile autoclaved transparent paper (three times to get an average area) and then placed on graph paper to determine the area . Wound contraction was calculated as the percentage reduction of the initial wound area. Wound healing was monitored by taking photographs on days 1, 3, 9, 12, and 15 after wounding. Wounds were considered closed (completely healed) if moist granulation tissue was no longer apparent and the wound was covered with new epithelium.
Estimation of proinflammatory and anti-inflammatory cytokine induction
Blood samples were collected from all animals of each group on days 1 and 9 after wounding. The levels of proinflammatory (TNFα and IL-6) and anti-inflammatory cytokines (IL-10) were estimated by performing enzyme-linked immunosorbent assays (ELISAs) using commercial kits. ELISA kits for the determination of TNFα (Cat. No. ab46070), IL-6 (Cat. No. ab100772), and IL-10 (Cat. No. ab100764) were obtained from Abcam Inc. (Cambridge, MA, USA). Assays were performed according to the manufacturer’s instructions. The cytokine concentrations were determined in pg/ml by plotting the graph for the standard. All experiments were performed in triplicate to ensure the accuracy of the observations.
Estimation of hydroxyproline and hexosamine
On days 3, 9, and 15 after wounding, a piece of skin from the healed wound area was collected and analyzed for its levels of hydroxyproline, which is the basic constituent of collagen. Tissues were dried in a hot air oven at 60-70°C to an equal weight and hydrolyzed in 6 N HCl at 130°C for 4 h in sealed tubes. The hydrolysate was neutralized to pH 7.0 with 0.1N KOH and subjected to chloramine-T oxidation for 20 min. The reaction was terminated by the addition of 0.4 M perchloric acid, and color was developed with the help of Ehrlich reagent at 60°C and measured at 557 nm using a UV/Vis spectrophotometer (Shimadzu) . To estimate the hexosamine levels, the weighed granulation tissues were hydrolyzed in 6 N HCl for 8 h at 98°C, neutralized to pH 7 with 4 N NaOH, and diluted with Milli-Q water. The hexosamine content of granulation tissues was estimated as described previously with minor modifications . The diluted solution was mixed with acetylacetone solution and heated to 96°C for 40 min. The mixture was cooled, and 96% ethanol was added, followed by the addition of r-dimethylamino-benzaldehyde solution (Ehrlich’s reagent). The solution was thoroughly mixed and kept at room temperature for 1 h, and the absorbance was measured at 530 nm using a double-beam UV/Vis spectrophotometer (Shimadzu). The amount of hexosamine was determined via comparisons with a standard curve.
A specimen sample was isolated from each group of rats on day 15 after wounding for histopathological examination. Skin specimens were immediately fixed in 10% (v/v) neutral-buffered formalin, and the fixative solution replaced every 2 days until the tissues hardened. Each specimen was embedded in a paraffin block, and thin sections (3 μm) were prepared and stained with Masson’s trichrome (to detect collagen fibers) and hematoxylin and eosin (H&E) (for general morphological observations). Slides were examined qualitatively under a light microscope for collagen formation, fibroblast proliferation, angiogenesis, epithelization, and granulation tissue formation by employing a light to intense scale (+ to +++) .
Data are expressed as the mean ± SD for each group of animals. Statistical analysis was performed with one-way analysis of variance. Dunnett’s post hoc test was used to determine the source of significant differences where appropriate. Data were analyzed using SigmaPlot (Version 11.0). A P value < 0.05 was considered statistically significant.
LJEE inhibited the growth of all organisms tested, but the efficiency of its inhibition was organism-specific. The zone of inhibition of LJEE ranged from 8.17 to 12.87 mm. Candida tropicalis (12.87 ± 0.09 mm) was the most sensitive to LJEE, followed by Staphylococcus aureus (10.96 ± 0.08 mm), Staphylococcus epidermidis (10.67 ± 0.11 mm), Candida albicans (9.32 ± 0.14 mm), and Escherichia coli (8.17 ± 0.09 mm). The MICs of LJEE ranged from 100 to 300 μg/disc, with the lowest MIC observed for Candida tropicalis.
Effect of LJEE on wound contraction
Effect of LJEE on proinflammatory cytokines (TNFα and IL-6) production
Effects of LJEE ointment on the production of TNFα, IL-6, and IL-10 in healed wounds on days 1 (d1) and 9 (d9) after wounding
243.7 ± 18.8
104.2 ± 16.4
432.7 ± 25.8
216.4 ± 22.5
93.5 ± 15.8
547.9 ± 31.4
10% (w/w) LJEE ointment
227.8 ± 19.4
88.1 ± 12.3
784.0 ± 28.3a
155.3 ± 17.9b
79.2 ± 17.3a
1038.6 ± 49.7b
0.2% (w/w) nitrofurazone ointment
203.5 ± 20.9a
67.0 ± 14.9b
811.5 ± 30.7b
143.7 ± 21.3b
40.6 ± 13.7b
1235.7 ± 41.2b
At 24 h after wounding, the IL-6 level in LJEE ointment-treated rats (88.1 ± 12.3 pg/ml) was slightly lower than that in the simple ointment-treated group (104.2 ± 16.4 pg/ml), whereas the IL-6 levels was significantly reduced (P < 0.05) to 79.2 ± 17.3 pg/ml on day 9 after wounding in the LJEE ointment-treated group (Table 1). Conversely, a high IL-6 level (93.5 ± 15.8 pg/ml) was observed on day 9 after wounding in simple ointment-treated rats. The IL-6 level in the 0.2% (w/w) nitrofurazone ointment-treated group (67.0 ± 14.9 pg/ml) on day 1 after wounding was significantly (P < 0.01) lower than that in the simple ointment-treated group, and the reduction in IL-6 levels was sustained (40.6 ± 13.7 pg/ml) on day 9 after wounding (Table 1).
Effect of LJEE on anti-inflammatory cytokine (IL-10) production
The IL-10 level after wounding in the simple ointment-treated group (day 1: 432.7 ± 25.8 pg/ml; day 9: 547.9 ± 31.4 pg/ml) was significantly (P < 0.01) lower than that in the 0.2% (w/w) nitrofurazone ointment-treated group (day 1: 811.5 ± 30.7 pg/ml; day 9: 1235.7 ± 41.2 pg/ml; Table 1). The IL-10 level in the 10% (w/w) LJEE ointment treated group was markedly elevated to 784.0 ± 28.3 and 1038.6 ± 49.7 pg/ml on days 1 and 9 after wounding, respectively (Table 1).
Effect of LJEE on the hydroxyproline and hexosamine contents during healing
Effects of LJEE ointment on the hexosamine and hydroxyproline content in granulation tissue on different days after wounding
Hexosamine (mg/100 mg of tissue)
Hydroxyproline (mg/g tissue)
0.20 ± 0.04
0.47 ± 0.06
0.68 ± 0.09
21.57 ± 1.17
33.51 ± 1.83
44.8 ± 2.17
10% (w/w) LJEE ointment
0.36 ± 0.06a
0.69 ± 0.08a
0.79 ± 0.07a
38.32 ± 2.03b
50.23 ± 2.11b
71.8 ± 2.46b
0.2% (w/w) nitrofurazone ointment
0.41 ± 0.09b
0.76 ± 0.05b
0.85 ± 0.06a
41.46 ± 1.92b
60.64 ± 2.42b
83.4 ± 2.73b
Effect of LJEE on the histopathological features of healed wounds
The histopathological scores on healed wounds from LJEE and nitrofurazone ointment-treated animals
10% (w/w) LJEE ointment
0.2% (w/w) nitrofurazone ointment
The significant reduction in wound size after LJEE ointment treatment was correlated with the histopathological findings of increased epithelization activity, angiogenesis, granulation tissue formation, and finally remodeling of the extracellular matrix. Collagen not only confers strength and integrity to the tissue matrix but also plays an important role in homeostasis and epithelialization in the later stages of wound healing . Hydroxyproline is an uncommon amino acid present in the collagen fibers of granulation tissues. Biochemical analysis revealed increased hydroxyproline content, which is a reflection of increased cellular proliferation and therefore increased collagen synthesis, after LJEE ointment treatment . Increased hexosamine content reflects the stabilization of collagen molecules via enhanced electrostatic and ionic interactions . Hence, enhanced hydroxyproline and hexosamine synthesis provides strength to repaired tissue and stimulates healing. Significant increases in hydroxyproline and hexosamine content were observed in the wounds after LJEE ointment, and these findings were supported by the histopathological data. The potent wound-healing capacity of LJEE, as evidenced by the wound contraction and increased levels of biochemical parameters in healing tissue, has thus validated the ethnotherapeutic claim.
Open wounds are particularly prone to infection, especially by bacteria, and they also provide an entry point for organics that cause systemic infections. Infected wounds heal less rapidly, and infection often results in the formation of unpleasant exudates and the production of toxins concomitantly with the killing of regenerating cells . Wide ranges of antibiotics are presently being used to treat wound infections in humans . However, due to their adverse effects and the presence of antibiotic-resistant organisms, researchers are now investigating the extracts of biologically active compounds isolated from plant species that are used in herbal medicine . The use of LJEE to treat various skin infections is justified by this work, as LJEE exhibited commendable activity against all the organisms tested. The external application of LJEE on wounds prevented the invasion of microbes through the wound, resulting in protection of the wound against infection by various organisms.
Strong TNFα and IL-6 induction after cutaneous injury was observed as early as 12–24 h after wounding, and these components play a major role in the inflammatory phase of wound healing by enhancing angiogenesis . Our study revealed that TNFα and IL-6 levels were slightly lower at 24 h after wounding in LJEE ointment-treated animals. It is thus apparent that the LJEE ointment did not interfere with macrophage-derived proinflammatory cytokines during the first stage of healing. However, LJEE ointment treatment elevated IL-10 levels on days 1 and 9 after wounding. IL-10 is an anti-inflammatory cytokine produced by various cells including macrophages and T lymphocytes . IL-10 appears to influence the wound-healing environment by decreasing the expression of proinflammatory/profibrotic mediators, resulting in decreased recruitment of inflammatory cells to the wound . Treatment with LJEE ointment increased the serum IL-10 concentration and simultaneously downregulated TNFα and IL-6 expression, especially on day 9 after wounding. There are reports that TNFα inhibits collagen formation and hydroxyproline production, which are essential for the final part of the proliferative phase in wound healing . The findings suggested that LJEE regulates anti-inflammatory and proinflammatory cytokines and ultimately the systemic immune pathways associated with them, thus leading to cellular proliferation.
In the current Chinese Pharmacopoeia, chlorogenic acid is officially used as the indicator compound to characterize the quality of this herb . Considerable chlorogenic acid content has been detected in LJEE. It has been demonstrated that chlorogenic acid strongly inhibits the production of TNFα and IL-6 by human peripheral blood mononuclear cells stimulated with staphylococcal exotoxins . Chlorogenic acid inhibits the synthesis of other mediators such as IL-1, interferon-gamma, monocyte chemotactic protein-1, and macrophage inflammatory protein-1a . Additionally, chlorogenic acid has strong bacteriostatic activity . Hence, the synergistic effect of the antimicrobial and anti-inflammatory activities of LJEE accelerated the wound healing process.
Recent studies with other plant extracts revealed that phytochemical constituents such as flavonoids, triterpenoids, and tannins can promote the wound-healing process [26–28]. As L. japonica is being used and cultivated in more countries, its chemical components have been extensively studied. Essential oil, organic acids, flavones, saponins, iridoids, and inorganic elements were isolated and identified as the primary components . Among them, essential oil and chlorogenic acid have demonstrated pharmacological effects, and they are considered the active compounds of L. japonica.
The results revealed the potential use of LJEE as an external treatment for wounds. The mechanism of action of LJEE was postulated to involve angiogenesis, collagen deposition, granulation tissue formation, epithelization, and wound contraction at the proliferative stage, and these actions are attributed to the synergistic effects of the strong antibacterial and anti-inflammatory effects of the active compounds in the extract such as chlorogenic acid. However, further study is needed to isolate the active ingredients that promote wound healing before LJEE can be used clinically. As L. japonica is ubiquitously and abundantly grown, it could be a fairly economical therapeutic agent for wound management as a prohealer as well as a modality for controlling abnormal healing.
The present study was supported by the grant from Pingtung Agricultural Biotechnology Park (PABP10019) of Taiwan.
- Gantwerker EA, Hom DB: Skin: histology and physiology of wound healing. Facial Plast Surg Clin North Am. 2011, 19: 441-453. 10.1016/j.fsc.2011.06.009.View ArticlePubMedGoogle Scholar
- Weiss SJ: Tissue destruction by neutrophils. N Engl J Med. 1989, 320: 365-376. 10.1056/NEJM198902093200606.View ArticlePubMedGoogle Scholar
- Lowry SF: Cytokine mediators of immunity and inflammation. Arch Surg. 1993, 128: 1235-1241. 10.1001/archsurg.1993.01420230063010.View ArticlePubMedGoogle Scholar
- Wang XJ, Han G, Owens P, Siddiqui Y, Li AG: Role of TGF beta-mediated inflammation in cutaneous wound healing. J Investig Dermatol Symp Proc. 2006, 11: 112-117. 10.1038/sj.jidsymp.5650004.View ArticlePubMedGoogle Scholar
- Peng LY, Mei SX, Jiang B, Zhou H, Sun HD: Constituents from Lonicera japonica. Fitoterapia. 2000, 71: 713-715. 10.1016/S0367-326X(00)00212-4.View ArticlePubMedGoogle Scholar
- Shang X, Pan H, Li M, Miao X, Ding H: Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol. 2011, 138: 1-21. 10.1016/j.jep.2011.08.016.View ArticlePubMedGoogle Scholar
- Zhang B, Yang RY, Liu CZ: Microwave-assisted extraction of chlorogenic acid from flower buds of Lonicera japonica Thunb. Sep Purif Technol. 2008, 62: 480-483. 10.1016/j.seppur.2008.02.013.View ArticleGoogle Scholar
- Byun MW, Jo C, Lee JW, Jo SK, Kim KS: Application of radiation technology to develop green tea leaf as a natural resource for the cosmetic industry. Radiat Phys Chem. 2004, 71: 485-487.Google Scholar
- Byun MW, Jo C, Jeon TW, Hong CH: Effects of gamma irradiation on color characteristics and biological activities of extracts of Lonicera japonica (Japanese honeysuckle) with methanol and acetone. Lebensm-Wiss U Technol. 2004, 37: 29-33.View ArticleGoogle Scholar
- Phillips I, King A: Standardization of susceptibility testing methods. J Chemother. 1997, 9 (Suppl 1): 13-18.PubMedGoogle Scholar
- Werner S, Breeden M, Hubner G, Greenhalgh DG, Longaker MT: Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse. J Invest Dermatol. 1994, 103: 469-473. 10.1111/1523-1747.ep12395564.View ArticlePubMedGoogle Scholar
- Woessner JF: The determination of hydroxyproline in tissue and protein samples containing small portion of this imino acid. Arch Biochem Biophys. 1961, 93: 440-447. 10.1016/0003-9861(61)90291-0.View ArticlePubMedGoogle Scholar
- Johansen PG, Marshall RD, Neuberger A: Carbohydrates in protein. 2. The hexose, hexosamine, acetyl and amide-nitrogen content of hen’s-egg albumin. Biochem J. 1960, 77: 239-247.View ArticlePubMedPubMed CentralGoogle Scholar
- Akkol EK, Koca U, Pesin I, Yilmazer D, Toker G, Yesilada E: Exploring the wound healing activity of Arnebia densiflora (Nordm.) Ledeb. by in vivo models. J Ethnopharmacol. 2009, 124: 137-141. 10.1016/j.jep.2009.03.019.View ArticlePubMedGoogle Scholar
- Landsman A, Taft D, Riemer K: The role of collagen bioscaffolds, foamed collagen, and living skin equivalents in wound healing. Clin Podiatr Med Surg. 2009, 26: 525-533. 10.1016/j.cpm.2009.08.012.View ArticlePubMedGoogle Scholar
- Ricard-Blum S, Ruggiero F: The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol. 2005, 53: 430-442. 10.1016/j.patbio.2004.12.024.View ArticlePubMedGoogle Scholar
- Black CE, Costerton JW: Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. Surg Clin North Am. 2010, 90: 1147-1160. 10.1016/j.suc.2010.08.009.View ArticlePubMedGoogle Scholar
- Atiyeh BS, Dibo SA, Hayek SN: Wound cleansing, topical antiseptics and wound healing. Int Wound J. 2009, 6: 420-430. 10.1111/j.1742-481X.2009.00639.x.View ArticlePubMedGoogle Scholar
- Miyasaki Y, Nichols WS, Morgan MA, Kwan JA, Van Benschoten MM, Kittell PE, Hardy WD: Screening of herbal extracts against multi-drug resistant Acinetobacter baumannii. Phytother Res. 2010, 24: 1202-1206.PubMedGoogle Scholar
- Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE: The phenotype of murine wound macrophages. J Leukoc Biol. 2010, 87: 59-67. 10.1189/jlb.0409236.View ArticlePubMedGoogle Scholar
- Sato Y, Ohshima T, Kondo T: Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun. 1999, 265: 194-199. 10.1006/bbrc.1999.1455.View ArticlePubMedGoogle Scholar
- Siqueira MF, Chehab L, Krothpali N, Behl Y, Yang J, Braasch C: Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia. 2010, 53: 378-388. 10.1007/s00125-009-1529-y.View ArticlePubMedGoogle Scholar
- Qian ZM, Li HJ, Li P, Chen J, Tang D: Simultaneous quantification of seven bioactive components in Caulis Lonicerae Japonicae by high performance liquid chromatography. Biomed Chromatogr. 2007, 21: 649-654. 10.1002/bmc.803.View ArticlePubMedGoogle Scholar
- Krakauer T: The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacol Immunotoxicol. 2002, 24: 113-119. 10.1081/IPH-120003407.View ArticlePubMedGoogle Scholar
- Ozçelik B, Kartal M, Orhan I: Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm Biol. 2011, 49: 396-402. 10.3109/13880209.2010.519390.View ArticlePubMedGoogle Scholar
- Havsteen BH: The biochemistry and medical significance of the flavonoids. Pharmacol Ther. 2002, 96: 67-202. 10.1016/S0163-7258(02)00298-X.View ArticlePubMedGoogle Scholar
- Annan K, Houghton PJ: Two novel lupane triterpenoids from Paullinia pinnata L. with fibroblast stimulatory activity. J Pharm Pharmacol. 2010, 62: 663-668.View ArticlePubMedGoogle Scholar
- Souza SM, Aquino LC, Milach AC, Bandeira MA, Nobre ME, Viana GS: Antiinflammatory and antiulcer properties of tannins from Myracrodruon urundeuva Allemão (Anacardiaceae) in rodents. Phytother Res. 2007, 21: 220-225. 10.1002/ptr.2011.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/226/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.